Isoproterenol in treatment of heart disease. Hemodynamic effects in circulatory failure

JAMA ◽  
1966 ◽  
Vol 197 (5) ◽  
pp. 315-320 ◽  
Author(s):  
W. C. Elliott
Keyword(s):  
Heart Disease ◽  
Circulatory Failure ◽  
Hemodynamic Effects

scholarly journals Hemodynamic Effects of Nitroglycerin, Propranolol, and Their Combination in Coronary Heart Disease

Circulation ◽  
1969 ◽  
Vol 39 (5) ◽  
pp. 623-632 ◽  
Author(s):  
LESLIE WIENER ◽  
EDWARD M. DWYER ◽  
J. WILLIAM COX
Keyword(s):  
Coronary Heart Disease ◽  
Heart Disease ◽  
Hemodynamic Effects

scholarly journals Hemodynamic Effects of Glucagon in Patients with Heart Disease

Circulation ◽  
1969 ◽  
Vol 39 (1) ◽  
pp. 38-47 ◽  
Author(s):  
JOHN F. WILLIAMS ◽  
RICHARD H. CHILDRESS ◽  
JEROLD N. CHIP ◽  
JOHN F. BORDER
Keyword(s):  
Heart Disease ◽  
Hemodynamic Effects

HEMODYNAMIC EFFECTS OF LIDOCAINE IN PATIENTS WITH HEART DISEASE

1970 ◽  
Vol 14 (1) ◽  
pp. 11
Author(s):  
R. R. SCHUMACHER ◽  
A. D. LIEBERSON ◽  
R. H. CHILDRESS ◽  
J. F. WILLIAMS
Keyword(s):  
Heart Disease ◽  
Hemodynamic Effects

Hemodynamic Effects of Dexmedetomidine in Critically Ill Neonates and Infants With Heart Disease

2012 ◽  
Vol 33 (7) ◽  
pp. 1069-1077 ◽  
Author(s):  
Francis Lam ◽  
Adnan T. Bhutta ◽  
Joseph D. Tobias ◽  
Jeffrey M. Gossett ◽  
Laura Morales ◽  
...  
Keyword(s):  
Heart Disease ◽  
Critically Ill ◽  
Hemodynamic Effects ◽  
Critically Ill Neonates ◽  
Neonates And Infants

A trimetazidin szerepe a diabeteses microangiopathia kezelésében ischaemiás szívbetegség esetén

2015 ◽  
Vol 156 (19) ◽  
pp. 765-768 ◽  
Author(s):  
Zsolt Fi ◽  
Gabriella Kovács ◽  
Veronika Szentes
Keyword(s):  
Public Health ◽  
Heart Disease ◽  
Ischemic Heart Disease ◽  
Diabetes Mellitus Type 2 ◽  
Ischemic Heart ◽  
Myocardial Tissue ◽  
Secondary Injury ◽  
Hemodynamic Effects

Diabetes is one of the largest public health problems nowadays. We have to consider appearance of micro- and macroangiopathic complications as early as the time of diagnosis. In diabetes mellitus type 2, one of the main complications is ischemic heart disease caused by atherosclerosis of the coronary arteries manifested clinically as angina pectoris and myocardial infarction. However, microangiopathy and secondary injury of myocardial tissue are also not uncommon complications. In the treatment of ischemic heart disease coronary interventions, medications dilating coronaries and decreasing blood pressure and heart rate are frequently applied. The authors draw attention to a drug having no hemodynamic effects, which improves the quality of life of patients via its effect on the metabolism of the myocardium. Orv. Hetil., 2015, 156(19), 765–768.

Sign in / Sign up

Export Citation Format

Share Document